I. Vision of the Chronic Obstructive Pulmonary Disease (COPD) Care Team

As the National Taiwan University Hospital (NTUH), we have always upheld a fine tradition of cultivating outstanding talent, developing forward-looking research, and integrating with the world's leading medical technologies. Our mission is to actively introduce clinical trials for new drugs and medical devices, pursue continuous research and quality improvement, and develop care for severe and difficult patients. We strive to provide high-quality, humanistic medical care and serve as a role model for the medical community. By utilizing case management combined with team-based care and an integrated medical system, we incorporate precision nutrition, pulmonary rehabilitation, and healthy lifestyle promotion. Simultaneously, we extend long-term care and community resources to provide patients with integrated care, ultimately improving the quality of life and prognosis of COPD patients.
 

II.    Development Features and Advantages of the COPD Care Team 

1. Institutional Strengths
   • Our hospital possesses outstanding medical talent and advanced medical technology.
   • We provide comprehensive medical specialties and professional categories, featuring dedicated case managers and abundant research resources.
   • We have continuously achieved the COPD Disease Care Quality Certification from the Joint Commission of Taiwan (JCT).
2. Talent Cultivation and Global Integration
   • We actively introduce clinical trials for new drugs and medical devices, alongside ongoing research and quality improvement.\
   • The team continuously cultivates top-tier medical talent and integrates with leading global medical technologies.
   • We specialize in the care of severe and difficult patients while actively integrating resources.
   • We pursue continuous innovative research and quality enhancement, publishing innovative research papers annually.
3. Precision Medicine
   • The team uses inspiratory flow rate assessment to guide correct medication as the core of care.
   • Through cross-departmental multi-team collaboration, we achieve precise personalized medicine.
   • We are the world’s first to develop "Using Peak Inspiratory Flow Rate Testing to Improve Inhaler Medication Techniques".
   • Prospective research has found that this testing can reduce the risk of severe acute exacerbations and death.
   • These results have been recognized by SCI international journals and invited for sharing at major hospitals, thoracic societies, and the APSR.
   • By integrating team care and medical systems, we incorporate precision nutrition, pulmonary rehabilitation, and healthy lifestyle promotion.
   • Care is extended to long-term care and community resources to provide integrated support, improving patients' quality of life and prognosis.
4. High-Impact Research (Research papers published in top 25% journals):
   • Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease Exacerbations: A Randomized Controlled Trial. (Ranking: 20.9%).
   • The impact of COPD-bronchiectasis association on clinical outcomes: insights from East Asian cohorts validating the ROSE criteria. (Ranking: 19%).
   • Lower Immunoglobulin G Levels Increased Exacerbation Risk in COPD: New Insights for Clinical Practice. (Ranking: 3.2%).
   • Predicting outcomes after hospitalisation for COPD exacerbation using machine learning. (Ranking: 19%).